|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00557 TIANYUAN HEALTH
Nominal 
0.580 0.000 (0.000%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 45,230 | -16.574% | 54,216 | 94,588 | 56,340 | 70,548 |
| Cost of Sales | (17,285) | -10.861% | (19,391) | (23,281) | (18,766) | 0 |
| Gross Profit | 27,945 | -19.756% | 34,825 | 71,307 | 37,574 | 70,548 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | 3,240 | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | (10,013) | 1151.625% | (800) | 1,299 | -- | -- | |
| Share of Results of Asso. & JCEs | (365) | -- | 242 | 184 | 549 | (4,897) | |
| Profit / (Loss) before Taxation | (28,778) | -28.677% | (40,349) | (19,063) | (125,847) | (162,882) | |
| Taxation | 1,821 | -- | 0 | 0 | 15,812 | (219) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | 23,777 | |
| Non-controlling Interests | 11,473 | 1.414% | 11,313 | 2,209 | 44,934 | (3,956) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (15,484) | -46.673% | (29,036) | (16,854) | (65,101) | (143,280) | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | 3,391 | -13.737% | 3,931 | 4,480 | 2,421 | 103 |
| Depreciation & Amortisation | 9,076 | -4.754% | 9,529 | 11,869 | 21,142 | 17,873 |
| Directors' Emoluments | 1,094 | -80.599% | 5,639 | 9,012 | 10,020 | 23,636 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Disclaimer |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -3.880 | -46.703% | -7.280 | -4.220 | -16.310 | -35.910 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.013 | -- | (0.076) | 0.041 | 0.132 | (0.293) |
| NBV per share ($) | 0.577 | -- | 0.562 | 0.642 | 0.671 | 0.829 |
| Remarks: | Real time quote last updated: 25/11/2024 10:40 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -5,606,000 |
| %Change | -14.673% |
| EPS / (LPS) | HKD -0.014 |
| NBV Per Share ($) | HKD 0.563 |